Telitacicept for Injection is a world's first-in-class dual-target fusion protein drug targeting BLyS/APRIL, with definite efficacy, favorable safety profile and a convenient once-weekly administration schedule that can significantly improve patient compliance.
Authentic
Guarantee
Fast Delivery
Privacy Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



